Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker cis P-tau by a Label-Free Electrochemical Immunosensor

Early detection of cis phosphorylated tau (cis P-tau) may help as an effective treatment to control the progression of Alzheimer’s disease (AD). Recently, we introduced for the first time a monoclonal antibody (mAb) with high affinity against cis P-tau. In this study, the cis P-tau mAb was utilized...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiravandi, Ayoub, Yari, Farzaneh, Tofigh, Nahid, Kazemi Ashtiani, Mohammad, Shahpasand, Koorosh, Ghanian, Mohammad-Hossein, Shekari, Faezeh, Faridbod, Farnoush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599477/
https://www.ncbi.nlm.nih.gov/pubmed/36291017
http://dx.doi.org/10.3390/bios12100879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599477/
https://www.ncbi.nlm.nih.gov/pubmed/36291017
http://dx.doi.org/10.3390/bios12100879

Ejemplares similares